Mary West is the Vice President of Clinical Operations at Talaris. Prior to joining the company in 2020, Mary worked for a number of different pharmaceutical and biotech companies over her 23 years of experience. Most recently, she held positions at Skyhawk Therapeutics, BlueRock Therapeutics and Alnylam Pharmaceuticals. At Alnylam, Mary led the clinical operations function for the company’s first submitted and approved product (Onpattro) in RNAi Therapeutics. Mary started her career in industry as a Clinical Research Associate at Parke-Davis Pharmaceuticals/Warner-Lambert (acquired by Pfizer in 2000) in Ann Arbor, MI. Mary has a BS in Dietetics from Michigan State University and MS in Project Management from Boston University.